Medical News

Teterboro, NJ ? One year after U.S. Food and Drug Administration (FDA) approval, BEI Medical Systems? Hydro ThermAblator? (HTA?) has an overall satisfaction rate of 95.5 percent with the 151 women available for a follow-up investigation. Results gained from test subjects, all between 30 and 50 years old, revealed that 92.1 percent of them had a substantial reduction in their heavy menstrual bleeding, called menorrhagia, and nearly half had complete cessation of menses.

Dr. Stephen Corson, medical director at BEI Medical Systems, is not surprised by the study?s latest results. “The HTA device was carefully designed to be a safe and very thorough method of destroying the uterine lining responsible for menorrhagia,” Corson says. “We are optimistic that more doctors will utilize the HTA as they become better aware of its obvious superiority. “

For nearly 20 years, endometrial ablation has been a viable option for the 2.5 million women who visit gynecologists each year with life-altering menorrhagia. However, many of the current global techniques are flawed. The article “Hysteroscopic Endometrial Ablation Using Free Heated Saline for the Treatment of Menorrhagia” in The Journal of the American Association of Gynecologic Laparoscopists states that these other methods “can be difficult to learn and frequently result in incomplete ablation. They also may result in complications such as perforation, damage to other organs, bleeding, air embolism, and infection. In addition, use of nonphysiologic distending solutions ? may result in fluid overload.”

After extensive research, the HTA was developed to address these concerns. The system is user friendly, employs rigorous safety measures, and ablates the entire uterine lining. The 10-minute, outpatient procedure requires no incisions. The technique can be safely and easily performed in a physician?s office under local anesthesia, decreasing patient anxiety. A hysteroscopic sheath is then inserted through the cervical canal and into the uterine cavity. The cervix forms a seal around the sheath before heated saline is allowed to circulate freely throughout the uterine cavity. The procedure can be viewed on a monitor by the physician and patient through the use of a hysteroscope.

For more information please contact Suzi Bruno or Jim Llewellyn at (818) 995-1290.
-

Teterboro, NJ ? One year after U.S. Food and Drug Administration (FDA) approval, BEI Medical Systems? Hydro ThermAblator? (HTA?) has an overall satisfaction rate of 95.5 percent with the 151 women available for a follow-up investigation. Results gained from test subjects, all between 30 and 50 years old, revealed that 92.1 percent of them had a substantial reduction in their heavy menstrual bleeding, called menorrhagia, and nearly half had complete cessation of menses.

Dr. Stephen Corson, medical director at BEI Medical Systems, is not surprised by the study?s latest results. “The HTA device was carefully designed to be a safe and very thorough method of destroying the uterine lining responsible for menorrhagia,” Corson says. “We are optimistic that more doctors will utilize the HTA as they become better aware of its obvious superiority. “

For nearly 20 years, endometrial ablation has been a viable option for the 2.5 million women who visit gynecologists each year with life-altering menorrhagia. However, many of the current global techniques are flawed. The article “Hysteroscopic Endometrial Ablation Using Free Heated Saline for the Treatment of Menorrhagia” in The Journal of the American Association of Gynecologic Laparoscopists states that these other methods “can be difficult to learn and frequently result in incomplete ablation. They also may result in complications such as perforation, damage to other organs, bleeding, air embolism, and infection. In addition, use of nonphysiologic distending solutions ? may result in fluid overload.”

After extensive research, the HTA was developed to address these concerns. The system is user friendly, employs rigorous safety measures, and ablates the entire uterine lining. The 10-minute, outpatient procedure requires no incisions. The technique can be safely and easily performed in a physician?s office under local anesthesia, decreasing patient anxiety. A hysteroscopic sheath is then inserted through the cervical canal and into the uterine cavity. The cervix forms a seal around the sheath before heated saline is allowed to circulate freely throughout the uterine cavity. The procedure can be viewed on a monitor by the physician and patient through the use of a hysteroscope.

For more information please contact Suzi Bruno or Jim Llewellyn at (818) 995-1290.
-